InhaleRx Limited (IRX.AX)

0.0280 0.0000 (0.00%) At close: 02:46PM AEST

InhaleRx Limited

414 La Trobe Street
Level 16
Melbourne, VIC 3000
Australia

https://inhalerx.com.au

Sector(s): Healthcare
Industry: Medical Devices
Full-time employees: 

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Darryl Davies B.Sc.	Chief Executive Officer	149.18k	N/A	N/A
Dr. Robert Jenny B.A., B.Sc., Ph.D.	Chief Scientific Officer	119.61k	N/A	N/A
Mr. Srinivasa Rao Suryadevara	Executive Vice President	N/A	N/A	1968
Mr. James Stephen Barrie CPA	Company Secretary & Non-Executive Director	N/A	N/A	N/A

Amounts are as of 31 December 2023, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in AUD.

Description

InhaleRx Limited engages in the developing and commercializing of medical drug delivery systems in Australia. It also develops inhaled drug formulations. Its solutions include Medihale inhaler, a sealed pod inhaler for use with inhaled formulations. The company was formerly known as Lifespot Health Ltd and changed its name to InhaleRx Limited in October 2021. InhaleRx Limited was incorporated in 2016 and is based in Melbourne, Australia.

Corporate governance

InhaleRx Limited’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.